Abstract Background Acute kidney injury is a severe complication following cardiopulmonary bypass (CPB) and is associated with capillary leakage and microcirculatory perfusion disturbances. CPB-induced thrombin release results in capillary hyperpermeability via activation of protease-activated receptor 1 (PAR1). We investigated whether aprotinin, which is thought to prevent thrombin from activating PAR1, preserves renal endothelial structure, reduces renal edema and preserves renal perfusion and reduces renal injury following CPB. Methods Rats were subjected to CPB after treatment with 33.000 KIU/kg aprotinin (n = 15) or PBS (n = 15) as control. A secondary dose of 33.000 KIU/kg aprotinin was given 60 min after initiation of CPB. Cremaster ...
Aprotinin reduces blood loss after cardiac operations and decreases the bleeding time. The mechanism...
The preoperative use of platelet inhibitors has increased the risk of bleeding during cardiac surger...
AbstractObjectives: Aprotinin is frequently administered systemically to patients undergoing cardiop...
Background: Aprotinin is a drug used to reduce postoperative bleeding in patients undergoing open he...
Background— Cardiac surgery with cardiopulmonary bypass (CPB) and cardioplegic arrest has been assoc...
ObjectiveThe purpose of the study was to determine the effects of aprotinin on (1) renal function, (...
Patients undergoing cardiac surgery with moderate hypothermic cardiopulmonary bypass (CPB) were allo...
A variety of studies have been performed on the preservation of hemostasis by aprotinin during cardi...
Background—The technique of deep hypothermic circulatory arrest (DHCA) for cardiothoracic surgery is...
AbstractIntroduction: The safety of aprotinin, especially when used with profound hypothermic circul...
AbstractBackground: Despite aprotinin being in widespread clinical use to prevent bleeding during ca...
Cardiopulmonary bypass (CPB) elicits derangements to the formed elements of blood because of the phy...
Background: Cardiopulmonary bypass (CPB) during cardiac surgery impairs microcirculatory perfusion a...
Bovine aprotinin, a reversible inhibitor of plasmin and kallikrein, has been clinically approved for...
Objective: The role of aprotinin in the prevention of lung reperfusion injury was investigated in th...
Aprotinin reduces blood loss after cardiac operations and decreases the bleeding time. The mechanism...
The preoperative use of platelet inhibitors has increased the risk of bleeding during cardiac surger...
AbstractObjectives: Aprotinin is frequently administered systemically to patients undergoing cardiop...
Background: Aprotinin is a drug used to reduce postoperative bleeding in patients undergoing open he...
Background— Cardiac surgery with cardiopulmonary bypass (CPB) and cardioplegic arrest has been assoc...
ObjectiveThe purpose of the study was to determine the effects of aprotinin on (1) renal function, (...
Patients undergoing cardiac surgery with moderate hypothermic cardiopulmonary bypass (CPB) were allo...
A variety of studies have been performed on the preservation of hemostasis by aprotinin during cardi...
Background—The technique of deep hypothermic circulatory arrest (DHCA) for cardiothoracic surgery is...
AbstractIntroduction: The safety of aprotinin, especially when used with profound hypothermic circul...
AbstractBackground: Despite aprotinin being in widespread clinical use to prevent bleeding during ca...
Cardiopulmonary bypass (CPB) elicits derangements to the formed elements of blood because of the phy...
Background: Cardiopulmonary bypass (CPB) during cardiac surgery impairs microcirculatory perfusion a...
Bovine aprotinin, a reversible inhibitor of plasmin and kallikrein, has been clinically approved for...
Objective: The role of aprotinin in the prevention of lung reperfusion injury was investigated in th...
Aprotinin reduces blood loss after cardiac operations and decreases the bleeding time. The mechanism...
The preoperative use of platelet inhibitors has increased the risk of bleeding during cardiac surger...
AbstractObjectives: Aprotinin is frequently administered systemically to patients undergoing cardiop...